Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A neuroblastoma associated with increased dopamine excretion.
No clinical trials have been registered for dopaminergic neuroblastoma.
6 publications have been identified in PubMed for dopaminergic neuroblastoma. Research spans Basic Science / Preclinical (83%) and Gene Therapy / Novel Therapeutics (17%).
Moura C (2025). [PMID: 40724598](https://pubmed.ncbi.nlm.nih.gov/40724598/). *Life (Basel, Switzerland)*. [Gene Therapy / Novel Therapeutics]
Pappa M (2025). [PMID: 40872458](https://pubmed.ncbi.nlm.nih.gov/40872458/). *Micromachines*. [Basic Science / Preclinical]
Veeramani C (2025). [PMID: 40265489](https://pubmed.ncbi.nlm.nih.gov/40265489/). *Archives of physiology and biochemistry*. [Basic Science / Preclinical]
Carvajal-Oliveros A (2024). [PMID: 39659447](https://pubmed.ncbi.nlm.nih.gov/39659447/). *Frontiers in cellular neuroscience*. [Basic Science / Preclinical]
Ribeiro M (2024). [PMID: 38987218](https://pubmed.ncbi.nlm.nih.gov/38987218/). *Biotechnology journal*. [Basic Science / Preclinical]
Chaipunko S (2024). [PMID: 39607552](https://pubmed.ncbi.nlm.nih.gov/39607552/). *Neurochemical research*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC